01
Low NADAC$0.063
→
Avg plan cost$0.221
Part D spend $339.1M
4× spread, current vs floor
Class summary at a glance.
Every drug in the N-methyl-D-aspartate Receptor Antagonist class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $339.1Mcombined across class
- Total Rx claims
- 9.6M2.1M unique beneficiaries
- Generic mfrs (active)
- 24across all molecules